Cho-Hao Lee

29PUBLICATIONS
50CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Innate immunityHaematological tumoursAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Sep 26, 2026
Immune Checkpoint Inhibitor Therapy and Risk of Glomerular Disease: A Large Propensity-Matched Cohort Study.

|Jun 26, 2026
Long-Term Cognitive Impairment After CAR-T Therapy Versus Autologous Stem Cell Transplantation: A Propensity Score-Matched Cohort Study.

|Jun 25, 2026
COVID-19 mRNA vaccination and immune-related adverse events in patients with cancer receiving immune checkpoint inhibitors: a target trial emulation study.

|Jun 11, 2026
Target Trial Emulation of Second-Generation Versus First-Generation Tyrosine Kinase Inhibitors in Adult Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia.

|May 06, 2026
Survival, Toxicity, and Economic Outcomes of Osimertinib Versus Second-Generation Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Metastatic Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer.

|Mar 18, 2026
Early intervention for high-risk smoldering multiple myeloma (SMM).

Po-Huang Chen, Hong-Jie Jhou, Ching-Liang Ho

Pageof 5

Frequent Collaborators

20 joint publications

Po-Huang Chen

15 joint publications

Hong-Jie Jhou

7 joint publications

Wei-Cheng Chang

4 joint publications

Hsin-Yu Chen